3次冲击要募85亿的惠科股份：业绩增长已放缓、总负债692亿，突击分红近6亿、募10亿补流、遭遇337调查与专利诉 讼。 惠科股份，这家号称"全球领先"的面板厂商，已经是第三次向A股大门发起冲刺了。按说事不过三，这次应该准备充 分、诚意满满了吧？可会诊君翻完这份2026年2月25日刚公布的"上会稿" 。 今儿咱就来给这家公司的IPO材料做个"深度体检"，看看这辆通往资本市场的快车上，到底藏了多少"故障码"。 一、业绩比川剧变脸还快 惠科股份在招股书里把自己夸得天花乱坠，什么"中国领先、世界知名"，什么"全球第三大面板厂商"。咱先不看广告看 疗效，直接翻到第40页的"主要财务数据"，这一看不得了，这业绩走势比过山车还刺激。 数据显示，2022年，公司归属于母公司所有者的净利润还是-14.21亿元，亏得那叫一个干脆；到了2023年，突然就变成 了25.82亿元，赚得那叫一个突然；2024年继续飙到33.20亿元，2025年上半年又是21.62亿元。 好家伙，这哪是搞实业的，这分明是请了财神爷坐镇啊！两年半时间，从巨亏到大赚，这业绩曲线比川剧变脸还快。公 司解释说2022年亏损是因为"行业景气度较低"，可问题是，同 ...

来源：《理财周刊》 半导体显示面板行业潮起潮落，身处其中的惠科股份，资本市场闯关之路却走得格外坎坷。从创业板IPO主动撤回，到转战主板后因 财务资料过期中止审核，几番起落间，公司始终站在上市关口反复试探。 如今，惠科股份再度冲刺深交所主板IPO，拟募资85亿元投向新型显示项目与补充流动资金，看似是企业迈向资本市场的正常布局， 却在光鲜的申报材料背后，藏着业绩周期波动、公司治理集中、资本对赌压顶等多重争议。 结合最新招股书、深交所审核问询及行业现实来看，这场资本闯关的成色，远没有表面看上去那般稳妥。 业绩高度绑定行业周期 盈利质量存忧 公司营收与利润深度依赖LCD面板景气度，呈现强周期特征。2022年行业下行期归母净利润亏损14.21亿元，2023~2024年随面板价格 回暖分别实现25.82亿元、33.20亿元盈利。但2025年1~9月，公司的营业收入出现了-0.36%的负增长，这让深交所也对其业绩稳定性提 出了更深层次的质疑。 图片来源：惠科股份官方招股书 盈利结构上，政府补助贡献显著，报告期内（2022年至2025年1~6月）计入当期损益的政府补助累计达53.75亿元，非经常性损益对利 润支撑明显。 财务 ...

Core Viewpoint - The article narrates the rise and fall of Baolide Holdings, a prominent luxury car dealership in China, founded by Yu Haijun, highlighting the impact of ambition, capital risks, and market changes on the company's trajectory [4][24]. Group 1: Company Background and Growth - Yu Haijun started his career in a textile company and identified the emerging demand for mid-to-high-end cars in China during the late 1990s, which was a largely untapped market at the time [8][9]. - In 2001, Baolide opened its first dealership in Hangzhou, marking the beginning of its expansion into the luxury car market [10]. - By 2023, Baolide had become one of the top 25 automotive dealer groups in China, with over 30 high-end dealerships and partnerships with more than 10 international luxury brands, serving nearly 500,000 customers [11][24]. Group 2: Capital and Financial Challenges - In 2016, Baolide received a significant investment of 645 million yuan from Minsheng Life Insurance, which included a risky buyback agreement that would impose heavy financial burdens if the company failed to go public by 2018 [14][15]. - By 2020, the company faced severe financial strain due to its inability to meet the IPO deadline, triggering the buyback clause and leading to annual interest payments of approximately 80 million yuan [15][16]. - Between 2016 and 2024, Baolide paid a total of 1.936 billion yuan in interest, with an average annual interest expense of 215 million yuan, exacerbating its financial difficulties [15][16]. Group 3: Decline and Bankruptcy - In 2024, Baolide's operational issues became public, including customer complaints about undelivered vehicles and financial mismanagement, leading to a significant loss of reputation [20][21]. - A critical event was the revelation that the company had mortgaged vehicle registration certificates to secure loans, which resulted in customers being unable to register their purchased vehicles [20][21]. - By August 2025, Baolide filed for bankruptcy, citing an inability to repay debts and insufficient assets, marking the end of its two-decade journey in the luxury car market [23][24].

Core Viewpoint - The financial maneuvers of Green Leaf Pharmaceutical, including the acquisition of a 25% stake in its subsidiary Nanjing Green Leaf and the introduction of high-interest financing, have drawn significant market attention due to their complexity and potential implications for the company's financial health [3][4][5]. Group 1: Acquisition and Financing Structure - Green Leaf Pharmaceutical announced the completion of a 25% stake buyback in Nanjing Green Leaf for approximately 1.086 billion yuan, with the stake now held by Nanjing Xinshi, a partnership involving Shandong Green Leaf and China Cinda Asset Management [3][6]. - The financing structure includes an 8.5% annual return for China Cinda, with a clear exit mechanism established through put options tied to Nanjing Green Leaf's future profitability and IPO plans [4][9]. - Nanjing Green Leaf is projected to achieve pre-tax net profits of 4.06 billion yuan in 2023 and 4.1 billion yuan in 2024, making it a core asset for Green Leaf Pharmaceutical [6][10]. Group 2: Financial Performance and Market Position - As of June 30, 2025, Green Leaf Pharmaceutical's capital debt ratio rose to 59.1%, primarily due to increased borrowings, with short-term loans reaching 7.668 billion yuan [8][9]. - Nanjing Green Leaf's main product, Lipusu, has faced pricing pressures and competition, impacting the company's revenue growth, which saw a decline of 1.3% year-on-year in 2024 [10][11]. - The company has 31 products in various stages of development in China, including 13 oncology products, and anticipates revenue growth driven by new product approvals and sales [11].

Core Viewpoint - Zhejiang Xinxing Tool Co., Ltd. is pursuing an IPO on the Shenzhen Stock Exchange's Growth Enterprise Market, facing challenges such as a low market share of 1.9%, declining gross margins, and a revenue structure heavily reliant on ODM manufacturing [2][6][18]. Company Overview - Xinxing Tool is a leading manufacturer of hole processing tools in China, focusing on the research, production, and sales of high-performance drilling tools, including annular and solid drills, used in high-end manufacturing sectors like steel structures, rail transportation, and energy equipment [2][3]. - The company has a market share of only 1.9% in the hole processing sector, indicating a highly competitive environment with many domestic players [6][12]. Financial Performance - Revenue for the years 2022 to the first half of 2025 was reported as follows: CNY 391 million, CNY 425 million, CNY 467 million, and CNY 244 million, respectively. Net profit figures were CNY 172 million, CNY 177 million, CNY 185 million, and CNY 98.5 million, showing modest growth [2][3]. - The gross margins for annular drilling products decreased from 58.98% in 2022 to 56.64% in the first half of 2025, while solid drilling products saw a decline from 56.59% to 49.22% during the same period [5][12]. Product Structure - The company's main products are categorized into annular drilling series and solid drilling series, which accounted for approximately 87.28% to 88.56% of total revenue during the reporting period [5][6]. - Annular drills are designed for efficient drilling in medium to thick steel plates, while solid drills are used for high-precision applications [4][5]. Sales and Distribution - Xinxing Tool employs a mixed sales model, with approximately 73.22% of revenue generated through distributors and 24.93% from direct sales to ODM customers [7][8]. - The company’s largest customer, Sanhuan Import and Export, contributed significantly to its revenue, accounting for 29.26% of total sales in 2022 [9][10]. Research and Development - The company's R&D expenses have been declining, with rates of 5.21%, 5.15%, 4.90%, and 4.82% from 2022 to the first half of 2025, which are below the industry average [12][13]. - As of mid-2025, Xinxing Tool employed 96 R&D personnel, with only 21 holding a bachelor's degree or higher, indicating a potential gap in advanced technical expertise [14][15]. Ownership and Investment - The company is primarily controlled by a family group, holding 92.65% of the shares, and has previously faced issues related to shareholding arrangements [16][18]. - In April 2025, Xinxing Tool attracted external investors, raising approximately CNY 250 million through a share transfer, which included several state-owned entities [16][18]. Challenges Ahead - The company faces multiple challenges in its IPO journey, including declining gross margins, reliance on ODM manufacturing for about 60% of its revenue, and historical issues related to shareholding and investment agreements [18][20].

Core Viewpoint - The article discusses the challenges faced by Guangxi Shuangying Group Co., Ltd. in its long and tumultuous journey towards an IPO, highlighting the company's financial struggles, repeated failures in meeting performance commitments, and the impact of external market conditions on its operations [4][12][17]. Group 1: IPO Journey and Challenges - Shuangying Group's IPO process has been fraught with difficulties, including multiple changes in sponsorship and target listing venues, leading to a prolonged timeline since its initial application in 2016 [5][6][10]. - The company has changed its IPO target from the New Third Board to the Shenzhen Main Board, then to Hong Kong, and finally to the Beijing Stock Exchange, reflecting the challenges in the automotive industry and its own operational setbacks [8][9]. - The company has faced significant pressure from investors due to previous failed performance commitments, leading to multiple rounds of buyback agreements with shareholders [12][14][16]. Group 2: Financial Performance and Operational Issues - Shuangying Group's main business is automotive seats, which accounted for approximately 69.15% of its revenue in 2024, but the company has struggled with profitability, showing a decline in gross and net profit margins [20][34]. - The company has reported a continuous negative operating cash flow for five consecutive years, totaling 717 million, indicating severe liquidity issues [40]. - The reliance on major clients, such as SAIC and Geely, has resulted in a lack of bargaining power, further complicating the company's financial situation [39]. Group 3: Strategic Decisions and Market Conditions - The company has engaged in questionable practices, such as transferring core assets to related entities to manage financial performance, which raises concerns about transparency and governance [23][30]. - Despite a significant increase in revenue in 2025, driven by breakthroughs in electric vehicle components, the company's gross margin has significantly decreased, particularly in its new energy vehicle seat assembly business [31][35]. - The company plans to raise 681 million through its IPO, with a substantial portion allocated to improving liquidity, reflecting its urgent need for financial stability [42].

Core Viewpoint - The fresh food sector in China is characterized as a challenging profitability battleground, with high wastage, low margins, and heavy operational demands leading to cautious capital investment from major players [1] Group 1: Company Overview - Qian Dama International Holdings Limited has officially submitted its IPO application to the Hong Kong Stock Exchange after nearly five years of anticipation since its initial listing plans in 2021 [2] - Qian Dama claims to be the largest community fresh food chain in China, with a market share of only 2.2%, despite leading the sector in gross merchandise volume (GMV) at 14.8 billion yuan in 2024 [3][6] - The company operates 2,938 community stores across 14 provinces and municipalities in China, expanding its product range from pork to a full array of fresh food categories [3] Group 2: Business Model and Efficiency - Qian Dama has introduced an innovative "daily clearance" model to combat high wastage in the fresh food industry, ensuring that all fresh products are sold on the same day, resulting in a stock turnover rate of 1-2 days and a wastage rate of around 5% [4] - The company's operational efficiency is reflected in its low inventory levels, with inventory constituting less than 3% of total assets [4] Group 3: Financial Performance and Challenges - Despite its operational efficiency, Qian Dama has faced stagnation in revenue, with figures remaining in the range of 11.7 billion yuan from 2023 to 2024, and a net profit margin of only 1.44% to 2.45% [5] - In the first three quarters of 2025, the company reported a 4.25% year-on-year decline in revenue to 8.36 billion yuan, with a net loss of 288 million yuan [5] Group 4: Market Dynamics and Competition - The Chinese fresh food retail market is valued at 6.57 trillion yuan, with the community fresh food segment accounting for approximately 616.2 billion yuan, indicating a highly fragmented market [6] - Qian Dama's market share is minimal compared to its competitors, with the top five players holding only 7.3% of the market [6] Group 5: Franchise Model and Issues - Qian Dama's revenue is heavily reliant on franchisees, with 95% of its income derived from supplying goods to franchise stores, which poses risks to franchisee profitability [11] - The franchise model has led to significant financial strain on franchisees, who face high operational costs and rigid fee structures, resulting in a situation where increased sales lead to greater losses [11][12] Group 6: Financial Pressures and Future Outlook - The company has not secured external financing for four years and is facing increasing financial pressure, with a significant portion of its liabilities tied to a "betting agreement" with early investors [14][15] - The impending IPO is seen as a critical move for the company, especially as key founding members have recently exited, raising concerns about the company's future direction [16][17]

Group 1 - The core viewpoint of the news is that Beijing Construction Resources Recycling Co., Ltd. (referred to as "Construction Resources") has responded to the first round of inquiry letters from the Beijing Stock Exchange, addressing issues related to innovation, market space, compliance, cyclical fluctuations in downstream industries, and the necessity and rationality of fundraising projects [2] Group 2 - Construction Resources was established in 2014 and primarily engages in the investment, construction, and operation of construction waste recycling projects, customized equipment integration services for construction waste disposal, production and sales of recycled products, and remediation of informal landfills and engineering sludge disposal [4] - The company plans to raise 277 million yuan through its IPO, which will be used for projects including the addition of temporary disposal facilities, the construction of an environmental new materials R&D center, a construction waste recycling disposal center, comprehensive upgrades of enterprise information systems, and to supplement working capital [4] Group 3 - From 2023 to the first three quarters of 2025, Construction Resources reported revenues of 588 million yuan, 643 million yuan, and 401 million yuan, with year-on-year changes of -4.88%, 9.44%, and -5.57% respectively; net profits were 67.06 million yuan, 56.67 million yuan, and 22.23 million yuan, with year-on-year changes of 112.40%, -15.43%, and -1.17% respectively [4] - The company's performance shows significant volatility and insufficient growth, with declining profitability indicators such as gross margin and net profit margin [4] Group 4 - Unlike typical IPO companies whose performance guarantees come from external investors, Construction Resources' performance guarantees come from minority shareholders of its subsidiary [5] - The inquiry letter indicates that Construction Resources has established a joint venture with Wuxi Urban Investment to participate in the Wuxi Hudai project, with shareholding ratios of 51% and 49% respectively; Wuxi Environmental acquired the 49% stake held by Wuxi Urban Investment in 2023 [5] - According to the performance guarantee agreement, Construction Resources must ensure that the joint venture achieves specific profit targets, including a net profit of no less than 2.5 million yuan in 2024 and a total net profit of no less than 6.5 million yuan over 2024-2025 [5]

Core Viewpoint - Zhejiang Jibao Intelligent Equipment Co., Ltd. (hereinafter referred to as Jibao) is striving for an IPO on the Beijing Stock Exchange, facing significant challenges including declining profits and internal issues related to acquisitions and business performance [2][11]. Group 1: IPO and Shareholder Dynamics - Jibao's actual controllers, Shen Jiangyong and Chen Qun, signed a bet agreement with institutions, triggering a buyback clause if the company fails to submit an IPO application by December 31, 2025 [2]. - In December 2023, institutional investors such as Wanlin International and Hainan Shenggang invested in Jibao, but Wanlin International planned to exit shortly after due to changes in the domestic capital market [5][8]. - The company submitted its IPO application on December 25, 2025, and received acceptance from the Beijing Stock Exchange on December 30, 2025 [8]. Group 2: Financial Performance - Jibao's revenue grew from 250 million yuan in 2022 to 356 million yuan in 2024, but net profit declined from approximately 46.79 million yuan in 2022 to about 38.90 million yuan in 2024, marking a decrease of 8.21% in 2023 [11][15]. - The company reported a goodwill impairment of approximately 14.85 million yuan in 2023 due to the underperformance of its acquired subsidiary, Qiaohong Machinery, which saw its net profit drop significantly [15][16]. - The gross margin for Jibao's main products has been declining, with the gross margin for machine tool auxiliary equipment dropping from 25.82% in 2022 to 15.50% in the first half of 2025 [19]. Group 3: Cost Control Measures - Jibao has been actively controlling costs, with R&D expenses consistently below the industry average, hovering around 4% to 5% [21]. - The company has employed a significant number of retired personnel, accounting for over 12% of its total workforce, which helps reduce costs in the short term [21].

Core Viewpoint - The article emphasizes the importance of cultivating a long-term capital ecosystem led by "patient capital" to support youth innovation in Beijing, aligning with the city's goal of becoming a national technology innovation center [1][2]. Group 1: Policy Framework and Long-term Capital Ecosystem - Beijing has implemented measures to establish a growth mechanism for future industry investments, laying a solid policy foundation for the development of patient capital [1][2]. - The city aims to optimize capital empowerment mechanisms and foster a long-term investment culture to unleash the potential of youth innovation [2]. Group 2: Mechanisms for Supporting Youth Innovation - A proposed mechanism includes the introduction of guidelines for government-led funds to participate in venture agreements, focusing on long-term investments in six key future industries [3]. - The suggestion includes eliminating short-term performance metrics in fund assessments and providing management fee subsidies for projects with investment periods exceeding five years [3]. Group 3: Investment Culture Transformation - The article advocates for a shift in investment logic from a financial-focused approach to a strategic cultivation model, encouraging funds to adopt milestone-based agreements linked to technological breakthroughs [4]. - It suggests that companies signing agreements without buyback or forced exit clauses should receive positive incentives during IPO reviews [4]. Group 4: Risks Associated with Venture Agreements - The article identifies hidden risks associated with venture agreements, including compliance risks, liquidity pressures, control risks, and insufficient policy alignment, which hinder the IPO process for youth innovation companies [5]. - It highlights that over 30% of companies in review may retain exit paths through hidden mechanisms despite appearing to terminate venture clauses [5]. Group 5: Recommendations for Risk Management - Recommendations include the accounting profession initiating a "compliance health support plan" for startups, providing comprehensive professional support to manage venture agreement risks [6]. - Suggested actions involve developing a liquidity warning system, conducting health checks on venture agreements, and offering training programs to strengthen compliance foundations for youth entrepreneurs [6].